📰 Iagnostics News
Page 70 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
September 1, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an oncology-focused company with advanced near-to-market
September 1, 2022
Chris Lee aims to transform healthcare fundraising through VentureBlick's fundraising platform and professional community SINGAPORE, Sept. 1, 2022 /PRNewswire/ -- Chris Lee, one of the most experienced healthcare executives having held senior positions including president of Medtronic Asia Pacific and head of Bayer Healthcare Asia Pacific, today announced his new role as the founder and CEO of VentureBlick, a platform aiming to transform healthcare fundraising by matching healthcare startups...
September 1, 2022
BEVERLY, Mass., Sept. 01, 2022 -- LexaGene Holdings, Inc., , an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic testing, is... | September 1, 2022
August 31, 2022
LINKÖPING, Sweden, Aug. 31, 2022 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is initiating a new business unit to drive innovation and product
August 30, 2022
Vancouver, British Columbia--(Newsfile Corp. - August 30, 2022) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an oncology-focused company with advanced
August 30, 2022
Optina Diagnostics' solutions enable specialists and primary care physicians to diagnose chronic diseases including Alzheimer's with reliable and precise retinal scans. SAN ANTONIO, Aug.
August 29, 2022
The "Europe Alzheimer's Disease Therapeutics and Diagnostics Market 2022-2028" report has been added to ResearchAndMarkets.com's offering. MARKET OUTLOOK This report on the European Alzheimer's
August 29, 2022
STOCKHOLM, Aug. 29, 2022 /PRNewswire/ -- Devyser has today been certified under the new, more comprehensive IVD Regulation that came into force on May 26, 2022. The certification, issued by
August 26, 2022
A new study that could have immediate implications for COVID-19 testing in schools found that with age-appropriate instructions, school-aged children can successfully use a nasal swab to obtain their own COVID-19 test specimen.
August 24, 2022
A paper-based diagnostic has been developed by Jinghong Li, Weimin Li, Ruijin Deng, and colleagues from Boston University for the identification of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high sensitivity.